ArticleBMJ open2022

Use of artificial intelligence to assess the risk of coronary artery disease without additional (non-invasive) testing: validation in a low-risk to intermediate-risk outpatient clinic cohort.

Casper G M J Eurlings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.